Evidence map›Paper›PMID 34744825›Full record

ArticleFrontiers in psychiatry2021

Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".

Meg J Spriggs, Hannah M Douglass, Rebecca J Park, Tim Read, Jennifer L Danby, Frederico J C de Magalhães, Kirsty L Alderton, Tim M Williams, Allan Blemings, Adele Lafrance and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Ten practical suggestions for setting up a psychedelic study.Journal of psychopharmacology (Oxford, England) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. The Emergence of Psilocybin in Psychiatry and Neuroscience.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Meg J SpriggsCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
Hannah M DouglassCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
Rebecca J ParkOxBREaD Research Group, Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
Tim ReadCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
Jennifer L DanbyCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
Frederico J C de MagalhãesCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
Kirsty L AldertonCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
Tim M WilliamsCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
Allan BlemingsCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
Adele LafranceSchool of Rural and Northern Health, Laurentian University, Sudbury, ON, Canada.
Dasha E NichollsDivision of Psychiatry, Department of Brain Sciences, Imperial College London, London, United Kingdom.
David ErritzoeCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
David J NuttCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
Robin L Carhart-HarrisCentre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London, United Kingdom.
Imperial College London · GBLaurentian University · CAOxford Research Group · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anorexia nervosaclinical trialeating disorderelectroencephalograph (EEG)magnetic resonance imaging (MRI)psilocybinpsychedelic-assisted therapypublic patient involvement (PPI)

Identifiers

PMID34744825
PMCPMC8563607
OpenAlexW3205506305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.